TABLE 3.
p‐Values for maximum, mean and median doses to OARs (including cardiac structures) investigated in this study (N = 15 patients)
| OAR | Maximum dose p‐value | Mean dose p‐value | Median dose p‐value |
|---|---|---|---|
| Non‐cardiac OARs | |||
| Esophagus | 0.004 | 0.003 | 0.001 |
| Spinal cord | 0.003 | 0.001 | 0.001 |
| Skin | 0.140* | 0.001 | 0.001 |
| Liver | 0.173* | 0.001 | 0.001 |
| Lungs | 0.009 | 0.001 | 0.001 |
| Stomach | 0.125* | 0.211* | 0.001 |
| Trachea | 0.009 | 0.001 | 0.001 |
| Cardiac structures | |||
| Aorta | 0.532* | 0.005 | 0.001 |
| Right atrium | 0.460* | 0.053* | 0.078* |
| Left atrium | 0.005 | 0.496* | 0.211* |
| Heart‐PTV | 0.003 | 0.03 | 0.088* |
| Right ventricle | 0.002 | 0.017 | 0.011 |
| Left ventricle | 0.005 | 0.004 | 0.003 |
| IVC | 0.955* | 0.027 | 0.078* |
| SVC | 0.570* | 0.001 | 0.001 |
| Pulmonary veins | 0.047 | 0.256* | 0.031 |
| Pulmonary trunk | 0.691* | 0.001 | 0.001 |
*Not statistically significant for p > 0.05.